FDA approves first drug for neurotrophic keratitis, a rare eye disease - FDA Press Releases

FDA approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare disease affecting the cornea (the clear layer that covers the colored portion of the front of the eye).

from Food and Drug Administration--Press Releases https://ift.tt/2Mqm3AU
via IFTTT